Clinical trial
The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial
NCT00217256 · Medtronic Vascular, Industry · Completed
Key facts
| NCT number | NCT00217256 |
|---|---|
| Title | The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial |
| Official title | A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions |
| Acronym | ENDEAVOR III |
| Lead sponsor | Medtronic Vascular, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | Percutaneous Coronary Stenting |
| Enrollment | 436 |
| Start date | Feb 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | Dec 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 27, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: